| Net Loss Per Share |
Net Loss Per Share The following tables present the calculation of basic and diluted net loss per share (in thousands, except share and per share amounts):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended September 30, |
|
Nine Months Ended September 30, |
|
2022 |
|
2021 |
|
2022 |
|
2021 |
| Numerator: |
|
|
|
|
|
|
|
| Net loss |
$ |
(11,818) |
|
|
$ |
(14,220) |
|
|
$ |
(40,471) |
|
|
$ |
(37,622) |
|
| Less: cumulative dividends on redeemable convertible preferred stock |
— |
|
|
(585) |
|
|
— |
|
|
(1,691) |
|
| Net loss attributable to common stock holders - basic and diluted |
$ |
(11,818) |
|
|
$ |
(14,805) |
|
|
$ |
(40,471) |
|
|
$ |
(39,313) |
|
| Denominator: |
|
|
|
|
|
|
|
| Weighted-average common shares outstanding - basic and diluted |
65,143,929 |
|
|
14,317,575 |
|
|
64,898,948 |
|
|
13,250,767 |
|
| Net loss per share |
|
|
|
|
|
|
|
| Net loss per share, basic and diluted |
$ |
(0.18) |
|
|
$ |
(1.03) |
|
|
$ |
(0.62) |
|
|
$ |
(2.97) |
|
The following outstanding potential common shares were excluded from the computation of diluted net loss per share attributable to common stockholders as of the end of the periods presented because their inclusion would have been antidilutive:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
September 30, 2022 |
|
September 30, 2021 |
|
|
|
|
|
|
|
|
|
| Options to purchase common stock |
4,464,125 |
|
|
8,513,298 |
|
|
|
|
|
|
|
|
|
|
| Redeemable convertible preferred stock |
— |
|
|
43,836,109 |
|
|
|
|
|
|
|
|
|
|
| Warrants |
— |
|
|
107,000 |
|
|
|
|
|
|
|
|
|
|
| Number of shares issuable from ESPP |
229,488 |
|
|
— |
|
|
|
|
|
|
|
|
|
|
| Restricted stock units |
7,184,995 |
|
|
— |
|
|
|
|
|
|
|
|
|
|
|
11,878,608 |
|
|
52,456,407 |
|
|
|
|
|
|
|
|
|
|
|